Exabis Library
Welcome to the e-CCO Library!
P343: The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease and the relationship with biochemical markers of disease activity
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P344 Effectiveness of ustekinumab in refractory Crohn’s disease: A real-life experience in a tertiary referral centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P344: Diverting ileostomy in Inflammatory Bowel Disease's surgery: the real clinical cost analysis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P344: Effectiveness and safety of switching patients with inflammatory bowel disease from originator infliximab to CT-P13: systematic review and meta-analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P344: Epidemiology of clostridium difficile infections in IBD over two decades
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P344: Non-adherence to medical therapy is associated with hospitalisations and the development of active disease in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P344: Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P344: Vitamin D-Induced alterations in Cytokine levels lower the risk of clinical relapse in ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P344: What our patients are looking for - the common fields of interest in IBD patients: A Google Trends Analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P345 Lack of anti-TNF drugs levels in fistula tissue: A reason for non-response in Crohn’s perianal fistula?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P345: Capsule endoscopy in the diagnostic process of suspected Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P345: Food-related quality of life in adults with Inflammatory Bowel Disease is influenced by restrictive eating behaviour, disease activity and surgery: a prospective multi-centre study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P345: Impact of aphthous colitis at diagnosis on Crohn’s disease outcomes
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P345: Inconsistency between electronic data of patient's adherence and self reported adherence score
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P345: Risk of long-term post-operative recurrence (POR) in Crohn’s disease patients with a first postoperative normal endoscopic assessment under thiopurine prevention
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P345: The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P345: The Great Continental Divide: use of anti-TNF therapy in paediatric inflammatory bowel disease is significantly different in North America compared with other parts of the world.
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P346 Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn’s disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P346: Chronic pouch failure rates after close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P346: Decreasing disparities in and use of systemic corticosteroid and disparities in use among paediatric patients with Crohn disease in a multicentre collaborative
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM